Limited Upside for AMD? HSBC Downgrades Stock to Hold
HSBC downgraded AMD after a big rally. Stock looks expensive now, limited short-term upside, but long-term outlook still strong.
HSBC downgraded AMD after a big rally. Stock looks expensive now, limited short-term upside, but long-term outlook still strong.
Garda raised bid to $21.80/share cash to buy Assertio, boosting stock ~17%. Deal gives shareholders higher, certain payout.
Eli Lilly states that a post-launch report of hepatic failure for Foundayo (orforglipron) is not plausibly linked to the drug. RBC Capital describes it as “statistical background noise.”
FDA may fast-track Clene’s ALS drug CNM-Au8 after strong results, offering hope for longer life and slower disease progression.
Long Lake is buying Amex GBT for $6.3B, boosting travel with AI. Shareholders get a big premium; brand stays unchanged.
Citi raised Frontier PT to $4.90 as Spirit shuts down, boosting ULCC’s growth outlook and short-term upside potential.